Literature DB >> 21860108

OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.

S M Amudhan1, U Sekar, K Arunagiri, B Sekar.   

Abstract

OBJECTIVES: Acinetobacter baumannii is a significant pathogen in health care settings. In recent years, an increase in carbapenem resistance among A. baumannii due to Ambler class B metallo-beta-lactamases or class D OXA carbapenamases has been reported. In this study we detected the presence of OXA carbapenamases and coproduction of metallo-beta-lactamases (blaVIM and blaIMP ) by phenotypic and genotypic methods in carbapenem resistant clinical isolates of Acinetobacter baumannii.
MATERIALS AND METHODS: A total of 116 consecutive, non-duplicate carbapenem resistant A. baumannii isolated from various clinical specimens were included in the study. The modified Hodge test and inhibitor potentiated disk diffusion tests were done for the screening of carbapenamase and metallo-beta-lactamase production, respectively. Polymerase chain reaction (PCR) was performed for the detection of OXA (blaOXA 23 like, blaOXA 24 like, blaOXA-51 like and blaOXA-58 like genes) and metallo-beta-lactamases (blaVIM and blaIMP ) genes. Gene sequencing was performed for representative isolates.
RESULTS: Among 116 A. baumannii, OXA genes were detected in 106 isolates. BlaOXA 51 like (n = 99) and blaOXA -23 like (n = 95) were the most common and they coexisted in 89 isolates. blaOXA-24 like gene was detected in two isolates of which one also carried blaOXA-51 like and blaOXA-58 like genes. The modified Hodge test was positive in 113 isolates. The metallo-beta-lactamase screening test was positive in 92 isolates. blavim was detected in 54 isolates of which 1 also carried the blaIMP gene.
CONCLUSIONS: blaOXA-23 like and bla OXA 51 like genes are the most common types of OXA carbapenamases while the blaVIM type is the most common type of metallo-beta-lactamase contributing to carbapenem resistance in clinical isolates of A. baumannii. The coproduction of OXA and metallo-beta-lactamases is not an uncommon phenomenon in A. baumannii.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21860108     DOI: 10.4103/0255-0857.83911

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  19 in total

1.  A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations.

Authors:  Agila Kumari Pragasam; Rani Diana Sahni; Shalini Anandan; Archa Sharma; Radha Gopi; Noorjahan Hadibasha; Priya Gunasekaran; Balaji Veeraraghavan
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.

Authors:  Sangeetha Rajenderan; Veeraraghavan Balaji; Shalini Anandan; Rani Diana Sahni; Giannoula S Tansarli; Matthew E Falagas
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

3.  Early insights into the interactions of different β-lactam antibiotics and β-lactamase inhibitors against soluble forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3.

Authors:  Krisztina M Papp-Wallace; Baui Senkfor; Julian Gatta; Weirui Chai; Magdalena A Taracila; Veerabahu Shanmugasundaram; Seungil Han; Richard P Zaniewski; Brian M Lacey; Andrew P Tomaras; Marion J Skalweit; Michael E Harris; Louis B Rice; John D Buynak; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

4.  Comparative Evaluation of Four Phenotypic Tests for Detection of Metallo-β-Lactamase and Carbapenemase Production in Acinetobacter baumannii.

Authors:  Aparna Shivaprasad; Beena Antony; Poornima Shenoy
Journal:  J Clin Diagn Res       Date:  2014-05-15

5.  Laboratory to Clinical Investigation of Carbapenem Resistant Acinetobacter baumannii Outbreak in a General Hospital.

Authors:  Mo Guo-Xin; She Dan-Yang; Guan Xi-Zhou; Cui Jun-Chang; Wang Rui; Cui Zhi-Gang; Chen Liang-An
Journal:  Jundishapur J Microbiol       Date:  2014-01-01       Impact factor: 0.747

6.  Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India.

Authors:  Saranya Vijayakumar; Radha Gopi; Priya Gunasekaran; Manjurekar Bharathy; Kamini Walia; Shalini Anandan; Balaji Veeraraghavan
Journal:  Infect Dis Ther       Date:  2016-08-23

7.  MUS-2, a novel variant of the chromosome-encoded β-lactamase MUS-1, from Myroides odoratimimus.

Authors:  C Al-Bayssari; S Kumar Gupta; F Dabboussi; M Hamze; J-M Rolain
Journal:  New Microbes New Infect       Date:  2015-06-27

8.  Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns.

Authors:  Hasan Ghajavand; Bahram Nasr Esfahani; Seyed Asghar Havaei; Sharareh Moghim; Hossein Fazeli
Journal:  Adv Biomed Res       Date:  2015-05-29

9.  Correlation of Oxacillinase Gene Carriage With the Genetic Fingerprints of Imipenem-Resistant Clinical Isolates of Acinetobacter baumannii.

Authors:  Zahra Zanganeh; Fereshteh Eftekhar
Journal:  Jundishapur J Microbiol       Date:  2015-09-08       Impact factor: 0.747

10.  Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009).

Authors:  David P Kateete; Ritah Nakanjako; Juliet Namugenyi; Joseph Erume; Moses L Joloba; Christine F Najjuka
Journal:  Springerplus       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.